Boehringer Ingelheim Announces Key Appointment
Erkan Tetik, who has served as Market Access Director at Boehringer Ingelheim Turkey for five years, has been appointed to the position of Global Market Access Manager at Boehringer Ingelheim Germany headquarters in the "Central Nervous System (CNS), Retinopathy and Emerging Technologies" Market Access Team.
During his tenure, Tetik undertook strategically important responsibilities at both the national level and in the Middle East, Turkey and Africa (META) region. He served as a member of the Board of Health Economics Policies at the Association of Pharmaceutical Research Companies (AİFD). He also represented the company in important roles at the European Federation of Pharmaceutical Industries Associations (EFPIA) and the Turkish Working Group of the American Association of Pharmaceutical Researchers and Manufacturers (RHRMA). Going forward, Erkan Tetik will be responsible at Boehringer Ingelheim Germany headquarters for bringing the company's drugs in Central Nervous System, a new therapeutic area in the company's investment plans, to the global market.Advertisement
Ad Space728 × 90
